Teligent Desoximetasone Ointment 0.25% Recall: Superpotent Drug Risk
Teligent recalls 0.25% Desoximetasone Ointment 15g tubes (Rx only) due to superpotent drug risk. This ointment may cause severe side effects if misused.
Recall notice
Superpotent Drug
Contact the company
What happened, in plain English
Teligent is recalling 0.25% Desoximetasone Ointment 15g tubes (Rx only) because it's a superpotent drug that can cause serious side effects if misused. This recall affects prescription-only products sold with specific NDC numbers. Read more at govinfonow.com/recall/41759-teligent-desoximetasone-ointment-0-25-recall-superpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41759-teligent-desoximetasone-ointment-0-25-recall-superpotent-drug-risk · Updated October 8, 2026 · FDA enforcement record: FDA #D-0787-2017
Cite this page
“Teligent Desoximetasone Ointment 0.25% Recall: Superpotent Drug Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41759-teligent-desoximetasone-ointment-0-25-recall-superpotent-drug-risk. Based on FDA recall #D-0787-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0787-2017%22&limit=1).
Why it’s dangerous
This ointment is extremely potent and can cause severe skin reactions, burns, or other serious side effects if used incorrectly or in higher doses than prescribed. It is intended for medical use only under a doctor's supervision.
Who’s affected
Prescription patients using this ointment for medical conditions. Those with sensitive skin or conditions requiring precise dosing are at higher risk.
How to tell if you have this one
Check for 15g tubes labeled 'Desoximetasone Ointment USP 0.25%' with NDC 52565-030-15. The product was sold with lot number 5760 and expired May 31, 2018.
- Brand
Teligent- Category
Drug
What to do — step by step
Check Product Details
Verify the product label for NDC 52565-030-15 and lot number 5760 to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed in Tennessee.
FDA distribution: “TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0787-2017 (April 7, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0787-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.